News
Gilead Sciences (NASDAQ:GILD) is a $95-billion market cap biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and selling treatments for...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow I am a value focused investor. Stocks rise and fall for many different reasons that we often cannot...
News
This article was written by Follow I’m an Equity Analyst and Accountant specializing in restaurant stocks, with a strong foundation in Business Administration and...
News
This article was written by Follow Investing in high-growth opportunities across industries, employing a value investing approach that prioritizes robust business models and strategic...
News
Q3 Earnings Review for Top US Banks JPMorgan Chase (NYSE:JPM), Citigroup (NYSE:C), and Wells Fargo (NYSE:WFC) reported Q3 earnings on October 13. Below we...
News
Starting and monetizing a blog may sound intimidating, but this process is entirely achievable if you do the right things. To start, you should...
News
Last weekend’s article was titled “Bulls Have the Ball,” and this was certainly the case for the S&P 500 (SPY) in the first half...
News
On our last coverage of NewtekOne (NASDAQ:NEWT) we suggested that the stock while beaten down to $15.31, still did not offer compelling return prospects....
News
Progyny (NASDAQ:PGNY) is a company you may not be familiar with, but it is definitely worth a look. Its fundamentals, growth, profitability, and niche...
News
Co-authored by Treading Softly. These days, the mindset of “a dollar saved is a dollar earned” rings exceptionally true. Everything from gasoline to eggs...
News
Listen below or on the go on Apple Podcasts and Spotify Steven Cress, head of Quantitative Strategy at Seeking Alpha, discusses the best dividend...
News
Warren Buffett has, from time to time, likened investing to baseball. The one big difference, he has asserted, is that you can choose to...
News
Being majority-owned by the Brazilian state might raise eyebrows among some readers, but Banco do Brasil (OTCPK:BDORY)(“BdB”) has nonetheless registered meaningful outperformance recently versus...
